Completed PHASE3 INTERVENTIONAL 2-arm NCT06440252

Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults

The Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults: a Randomised, Double-blind, Placebo-controlled Crossover Study

Sponsor: RDC Clinical Pty Ltd

Conditions Circulatory; Change

Interventions Grape Seed Extract Maltodextrin

Updated 7 times since 2024 Last updated: Mar 4, 2026 Started: Oct 31, 2024 Primary completion: Dec 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06440252, this PHASE3 trial focuses on Circulatory; Change and remains completed. Sponsored by RDC Clinical Pty Ltd, it has been updated 7 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Mar 2026 — Present [monthly]

Completed PHASE3

Status: Active Not Recruiting → Completed
Dec 2025 — Mar 2026 [monthly]

Active Not Recruiting PHASE3

Status: Recruiting → Active Not Recruiting
Aug 2025 — Dec 2025 [monthly]

Recruiting PHASE3
Jan 2025 — Aug 2025 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Nov 2024 — Jan 2025 [monthly]

Not Yet Recruiting PHASE3

▶ Show 2 earlier versions

Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RDC Clinical Pty Ltd

Data source: RDC Clinical Pty Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brisbane, Australia